Does Olive Oil Raise Blood Pressure? Two 2026 Trials, Read Honestly

Short answer: no. Olive oil does not raise blood pressure — its sodium column is effectively zero, and the landmark Mediterranean-diet trial built its entire result on people eating more of it. But the sharper question in 2026 is the reverse one: does olive oil lower blood pressure enough to treat it like medicine? Two randomized trials published this spring say: not by itself.

VERDICT — No, it does not raise blood pressure

What the 2026 evidence shows: neither concentrated olive-leaf polyphenols (440 mg/day for 8 weeks) nor 40 g/day of extra-virgin olive oil moved resting blood pressure beyond placebo in controlled trials. The oil remains a green-column fat — the benefit comes from what it replaces, not from any medicinal dose effect.

Sources: PLoS ONE, March 2026 (PMID 41805711); Pregnancy Hypertension, March 2026 (PMID 41520410). Links in the text below.

Trial One: The Olive Extract That Lost to a Placebo

The most useful nutrition studies are the ones that fail cleanly, and the first 2026 paper is exactly that. A team at the University of Antwerp recruited 56 adults with systolic blood pressure at or above 130 mmHg — elevated, not yet a disease — and gave half of them a standardized dry olive extract capsule every day for eight weeks. The dose was not homeopathic: each capsule carried 440 mg of olive dry extract, standardized to about 123.5 mg of oleuropein and 25 mg of hydroxytyrosol, the two polyphenols that supplement marketing treats as the magic. The other half got an identical placebo (PMID 41805711, PLoS ONE, March 2026).

Both groups' blood pressure came down. The extract group averaged an 8.3 mmHg systolic drop; the placebo group averaged 7.3 mmHg. The between-group difference was not statistically significant — which, translated out of journal-speak, means the olive extract performed no better than an empty capsule and a scheduled appointment. Cholesterol, LDL and apo B fell in both arms too, again with no real difference. The authors' own conclusion is admirably blunt: the extract was well tolerated, but no significant hypotensive benefit was observed, and the response paralleled typical placebo effects seen in hypertension trials.

This matters for our readers for one reason: "olive polyphenols lower blood pressure" is one of the most repeated supplement claims of the decade, and the literature behind it is genuinely mixed. This trial is now the most recent datapoint in that stack, and it points the same direction as the skeptics.

Trial Two: Real Extra-Virgin Oil, Same Quiet Verdict on Pressure

The second trial, published the same month, tested the actual food instead of a capsule. Researchers randomized healthy reproductive-aged women to 40 grams of extra-virgin olive oil per day — about three tablespoons — or an identical daily dose of sunflower-seed oil, for eight weeks, double-blind, with compliance above 97% (PMID 41520410, Pregnancy Hypertension, March 2026).

Resting blood pressure: no difference between the groups. Vessel distensibility: no difference. What did move — fasting insulin down, the inflammatory chemokine MCP-1 down — was metabolic and anti-inflammatory, and the MCP-1 reduction correlated with systolic pressure within the olive group (r = 0.59). LDL cholesterol ticked up slightly. The honest summary: eight weeks of three daily tablespoons of EVOO did not remodel cardiovascular function in healthy young women, even as it nudged some metabolic markers the right way.

Put the two 2026 trials together and you get a clean, consistent answer to the question in the headline. Olive oil does not push blood pressure up — there is no mechanism and no signal for that in either trial or in the wider literature. But the romantic idea that it actively pulls blood pressure down as a stand-alone treatment took two more body shots this spring.

The Numbers, Side by Side

Both trials in the frame this site uses everywhere — what was tested, at what dose, against what control, and what actually moved:

Where the Olive Oil Story Is Actually Strong

So why does olive oil keep its green rating here and its reputation everywhere else? Because the evidence for olive oil was never really about pressure dose-response — it is about substitution. The landmark PREDIMED randomized trial found that a Mediterranean diet supplemented with extra-virgin olive oil reduced major cardiovascular events by roughly 30% compared with a low-fat control diet. The oil in that trial was not a pill taken on top of an unchanged diet; it replaced butter, margarine and other fats in the pattern.

That distinction is the entire ballgame. A tablespoon of olive oil adds roughly zero sodium and about 120 calories. The tablespoon of butter it replaces adds zero sodium too — butter's problem is saturated fat, not salt — but the salty vehicles butter usually rides in on (biscuit dough, pastry, salted butter spreads on bread) are a different story. And the bottled, oil-based dressings and margarines it displaces on the shelf can carry real sodium: a standard coleslaw dressing in our database runs 161.5 mg per tablespoon. Swap decisions like that are where the two columns actually move.

In our own database, olives and olive oil sit in the green column — the oil carries effectively no sodium per serving, and the fruit itself (the database entry most readers search as "olive") stays under the 140 mg green line per serving. The 2026 trials do not change that rating. They change the reasoning: olive oil is a good default fat, not a treatment.

What To Do With This on Monday Morning

Three moves that survive contact with this evidence:

• Keep olive oil as your default added fat — for the sodium column, for the substitution effect, and because the pattern-level evidence (PREDIMED and its successors) is far stronger than any single-ingredient trial.
• Do not buy olive-polyphenol supplements for blood pressure. The newest placebo-controlled trial found no effect beyond placebo at a supplement-grade dose. If you enjoy the foods, eat the foods.
• Watch what the oil replaces, not the oil itself. The swap that helps blood pressure is oil-instead-of-salty-spread, not oil-instead-of-nothing-on-top-of-already-salty-food.

And the standing caveat, as always on this desk: both 2026 trials were small (56 and 27 completers), short (8 weeks), and run on specific populations — one Belgian adults group, one cohort of healthy young women. They are good enough to answer the narrow question they asked, and too small to settle every claim in the olive-oil universe. We will keep the file open.